GFAP and central nervous system cancer: Since GFAP is highly expressed in neuroprogenitor and neural stem cells that can give rise to gliomas as well as in gliomas themselves, such mice provided the opportunity to monitor effects of DN-ATF5 on both glioma formation and persistence.